Botanix Pharmaceuticals Ltd (ASX:BOT)

APAC company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - BOT

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - BOT

  • Market CapAUD0.000m
  • SymbolASX:BOT
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINAU000000BOT2

Company Profile

Botanix Pharmaceuticals Ltd is a clinical stage cannabinoid therapeutics company. The company focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne.Botanix Pharmaceuticals Ltd is a clinical stage medical dermatology company. It is engaged in developing medical dermatology products for treating skin diseases including acne, psoriasis and atopic dermatitis.

Latest BOT news

Currently there for this company. Visit our news hub for other news .